About PreventionGenetics
PreventionGenetics is a company based in Marshfield (United States) founded in 2004 by James Weber was acquired by Exact Sciences in January 2022. The company has 205 employees as of December 31, 2022. PreventionGenetics offers products and services including PGnome, PGxome, PGmax, and Custom Panels. PreventionGenetics operates in a competitive market with competitors including Omniome, Novogene Corporation, Tessera Therapeutics, Phase Genomics and HitGen, among others.
- Headquarter Marshfield, United States
- Employees 205 as on 31 Dec, 2022
- Founders James Weber
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Preventiongenetics, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
205
as on Dec 31, 2022
-
Acquired by
Exact Sciences
(Jan 09, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PreventionGenetics
PreventionGenetics offers a comprehensive portfolio of products and services, including PGnome, PGxome, PGmax, and Custom Panels.
Comprehensive DNA testing for clinical genetic diagnosis.
Advanced genetic testing for identifying variants.
Tailored DNA tests for specific genetic disorders.
Specialized panels for various disease categories.
People of PreventionGenetics
Unlock access to complete
Unlock access to complete
Leadership Team
105 people
Software Development Team
103 people
Screening Team
78 people
Senior Team
62 people
Sales and Marketing
30 people
Data Analysis and Operations Team
29 people
Human Resources and Administration
28 people
Operations Team
23 people
Unlock access to complete
Funding Insights of PreventionGenetics
Detailed funding history for PreventionGenetics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in PreventionGenetics
PreventionGenetics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Exact Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Non-invasive molecular diagnostic tests for cancer detection are provided.
|
Locked | Locked | Locked |
Investor details for PreventionGenetics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PreventionGenetics
Investment portfolio details for PreventionGenetics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PreventionGenetics
Detailed financials for PreventionGenetics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Preventiongenetics Comparisons
Peer comparison for PreventionGenetics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PreventionGenetics
PreventionGenetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Novogene Corporation, Tessera Therapeutics, Phase Genomics and HitGen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
New genome engineering technology is provided for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Laboratory and computational services for DNA proximity analysis are provided.
|
|
| Locked | Locked | Locked |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Next-generation gene sequencing and multi-omics technologies are provided.
|
Detailed competitors of PreventionGenetics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Preventiongenetics
Complete news archive for PreventionGenetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PreventionGenetics
PreventionGenetics was founded in 2004.
PreventionGenetics is headquartered in Marshfield, United States. It is registered at Marshfield, Wisconsin, United States.
James Weber is the current CEO of PreventionGenetics. They have also founded this company.
As of Dec 31, 2022, the latest employee count at PreventionGenetics is 205.
PreventionGenetics was founded in 2004 in Marshfield, United States. Sequencing services and duplication tests for clinical genes are offered within the genetic diagnostics sector. Whole-exome sequencing tests are performed using the PGxome platform. DNA banking is facilitated through the PGDNA bank. Additional tests, including KATNB1 Gene Sequencing and the Parkinson Disease and Parkinsonism Sequencing Panel, are available to support clinical applications.
PreventionGenetics's top competitors include Tessera Therapeutics, Novogene Corporation and Phase Genomics.
PreventionGenetics offers PGnome, PGxome, PGmax, and Custom Panels.
PreventionGenetics has 1 investor. Key investors include Exact Sciences.